Search research articles
Contact Us
Filters
Showing results (11-20 of 62) with videos related to
Page
of 7
Sort By:
Journal of Advanced Research
|
May 14, 2025
Revealing the multiple faces of LRG1: gene expression, structure, function, and therapeutic potential
Ding Wang, Di Di, Bo Jiang, et al.
Oncology Letters
|
January 25, 2019
Moesin is an independent prognostic marker for ER-positive breast cancer
Lifeng Yu, Lin Zhao, Huizhe Wu, et al.
Journal of Cancer
|
April 25, 2020
Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood
Yalun Li, Huizhe Wu, Chengzhong Xing, et al.
Frontiers in Cell and Developmental Biology
|
December 23, 2021
The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer
Senxu Lu, Xiangyu Ding, Yuanhe Wang, et al.
Japanese Journal of Clinical Oncology
|
July 20, 2016
HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy
Haishan Zhao, Zhaojin Yu, Lin Zhao, et al.
Oncology Reports
|
July 18, 2018
High expression of microRNA‑31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin
Yalun Li, Shijie Xin, Huizhe Wu, et al.
Theranostics
|
May 22, 2023
The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer
Min Liu, Subo Zhang, Heng Zhou, et al.
Frontiers in Oncology
|
September 7, 2021
Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis
Xiaoyun Hu, Qiuchen Chen, Hao Guo, et al.
Cancer Science
|
April 24, 2012
Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients
Xiuli Yang, Duo Liu, Huizhe Wu, et al.
Theranostics
|
June 10, 2024
Distinctive tumorigenic significance and innovative oncology targets of SUMOylation
Heng Zhou, Na Deng, Yanshu Li, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 62) with videos related to
Sort By:
Page
of 7
Journal of Advanced Research
|
May 14, 2025
Revealing the multiple faces of LRG1: gene expression, structure, function, and therapeutic potential
Ding Wang, Di Di, Bo Jiang, et al.
Oncology Letters
|
January 25, 2019
Moesin is an independent prognostic marker for ER-positive breast cancer
Lifeng Yu, Lin Zhao, Huizhe Wu, et al.
Journal of Cancer
|
April 25, 2020
Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood
Yalun Li, Huizhe Wu, Chengzhong Xing, et al.
Frontiers in Cell and Developmental Biology
|
December 23, 2021
The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer
Senxu Lu, Xiangyu Ding, Yuanhe Wang, et al.
Japanese Journal of Clinical Oncology
|
July 20, 2016
HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy
Haishan Zhao, Zhaojin Yu, Lin Zhao, et al.
Oncology Reports
|
July 18, 2018
High expression of microRNA‑31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin
Yalun Li, Shijie Xin, Huizhe Wu, et al.
Theranostics
|
May 22, 2023
The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer
Min Liu, Subo Zhang, Heng Zhou, et al.
Frontiers in Oncology
|
September 7, 2021
Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis
Xiaoyun Hu, Qiuchen Chen, Hao Guo, et al.
Cancer Science
|
April 24, 2012
Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients
Xiuli Yang, Duo Liu, Huizhe Wu, et al.
Theranostics
|
June 10, 2024
Distinctive tumorigenic significance and innovative oncology targets of SUMOylation
Heng Zhou, Na Deng, Yanshu Li, et al.
Page
of 7